Paul Hudson, Sanofi CEO (Jeremy Paoloni/Abaca/Sipa USA(Sipa via AP Images))

Sanofi, Ope­nAI, For­ma­tion Bio an­nounce AI drug de­vel­op­ment part­ner­ship

French phar­ma­ceu­ti­cal gi­ant Sanofi will work with the tech pow­er­house Ope­nAI and New York-based start­up For­ma­tion Bio to de­vel­op AI-pow­ered soft­ware in drug R&D, the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.